Literature DB >> 12401365

Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry.

Ardeshir Amirkhani1, Eva Heldin, Karin E Markides, Jonas Bergquist.   

Abstract

Concentrations of tryptophan and its metabolites in plasma are of great interest in determining proper diagnosis and medication of several neurological diseases like, for example, Alzheimer's disease. A method of standard addition was developed to determine total level of tryptophan and two of its metabolites, kynurenine and kynurenic acid, in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry. Plasma samples were simply deproteinized by addition of diluted perchloric acid. Samples were then mixed with trichloroacetic acid and injected onto a capillary column. Analytes were separated by a fast gradient elution of the injected samples. Detection was performed by sheathless electrospray tandem mass spectrometry in the multiple reaction monitoring mode. Linear calibration curves were obtained for spiked plasma sample with up to 100% of the expected analytes concentrations. The determined concentrations were well within ranges previously reported (i.e., 6 nM-95 microM) and limit of detections were around 3 nM for each analyte. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401365     DOI: 10.1016/s1570-0232(02)00572-x

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  16 in total

Review 1.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

2.  IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.

Authors:  Lauren M F Merlo; Elizabeth Pigott; James B DuHadaway; Samantha Grabler; Richard Metz; George C Prendergast; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

3.  Clinical significance of simultaneous determination of serum tryptophan and tyrosine in patients with lung cancer.

Authors:  Ya-Ping Ren; Ai-Guo Tang; Qian-Xuan Zhou; Zhong-Yuan Xiang
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

4.  Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.

Authors:  Alexander J Muller; James B DuHadaway; Daniel Jaller; Peter Curtis; Richard Metz; George C Prendergast
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

5.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Authors:  Alexander J Muller; Madhav D Sharma; Phillip R Chandler; James B Duhadaway; Mary E Everhart; Burles A Johnson; David J Kahler; Jeanene Pihkala; Alejandro Peralta Soler; David H Munn; George C Prendergast; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

6.  Low tryptophan levels are associated with postoperative delirium in the elderly.

Authors:  Thomas N Robinson; Christopher D Raeburn; Erik M Angles; Marc Moss
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

7.  The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.

Authors:  Grant N Scott; James DuHadaway; Elizabeth Pigott; Natalie Ridge; George C Prendergast; Alexander J Muller; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.

Authors:  Marita C Barth; Neil Ahluwalia; Thomas J T Anderson; Gregory J Hardy; Sumita Sinha; Jose A Alvarez-Cardona; Ivy E Pruitt; Eugene P Rhee; Richard A Colvin; Robert E Gerszten
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

9.  Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

Authors:  Sanjeev Kumar; William P Malachowski; James B DuHadaway; Judith M LaLonde; Patrick J Carroll; Daniel Jaller; Richard Metz; George C Prendergast; Alexander J Muller
Journal:  J Med Chem       Date:  2008-03-05       Impact factor: 7.446

10.  Quantification of IDO1 enzyme activity in normal and malignant tissues.

Authors:  Lijie Zhai; Erik Ladomersky; April Bell; Corey Dussold; Krislyn Cardoza; Jun Qian; Kristen L Lauing; Derek A Wainwright
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.